TB-500 (Thymosin Beta-4): Actin Sequestration and Angiogenesis in Animal Models

Thymosin Beta-4 (TB-4) is a 43-amino-acid G-actin-sequestering peptide first isolated from calf thymus [1]. The synthetic research analog commonly referred to as TB-500 corresponds to the full-length sequence and has become a frequently studied probe for mechanisms of cytoskeletal dynamics and tissue regeneration in preclinical systems.

The defining biochemical property of TB-4 is its high-affinity binding to monomeric G-actin via a conserved N-terminal motif, which buffers the intracellular G-actin pool and modulates F-actin polymerization kinetics [2]. This actin-buffering activity contributes to the peptide’s role in cell migration — a finding repeatedly demonstrated in scratch-wound assays using cultured keratinocytes and endothelial cells [3].

Beyond actin binding, preclinical studies have characterized TB-4 as a potent angiogenic factor. In a murine hindlimb-ischemia model, intramuscular administration increased capillary density and improved perfusion compared with vehicle controls [4]. In cultured human umbilical vein endothelial cells (HUVECs), TB-4 enhanced tube formation and upregulated VEGF expression [3].

Cardiac research has also examined TB-4. In a mouse coronary ligation model, systemic TB-4 reactivated epicardial progenitor cells, increased neovascularization in the infarct border zone, and reduced scar volume on histology [5]. Separate work in zebrafish has shown a conserved role for thymosin beta family peptides in cardiomyocyte migration during development [6].

For laboratory work involving lyophilized TB-500 reconstitution, researchers typically dissolve the peptide in bacteriostatic water and store aliquots at −20 °C to preserve the labile N-terminal acetyl group. Frontier Peptide Labs offers a research-grade TB-500 Capsule format (60 ct, 500 mcg) for laboratory and analytical research use only.

References

1. Low TL, Hu SK, Goldstein AL. Complete amino acid sequence of bovine thymosin beta 4. Proc Natl Acad Sci U S A. 1981;78(2):1162-6. PubMed: 6940133
2. Safer D, et al. Thymosin beta 4 and Fx, an actin-sequestering peptide. J Biol Chem. 1991;266(7):4029-32. PubMed: 1999398
3. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-8. PubMed: 10469335
4. Smart N, et al. Thymosin beta-4 induces adult epicardial progenitor mobilization. 2007;445(7124):177-82. DOI: 10.1038/nature05383
5. Bock-Marquette I, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration. 2004;432(7016):466-72. DOI: 10.1038/nature03000
6. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-9. DOI: 10.1016/j.molmed.2005.07.004